InvestorsObserver
×
News Home

Is SCYNEXIS Inc (SCYX) a Smart Choice in Drug Manufacturers - Specialty & Generic Monday?

Monday, October 23, 2023 09:50 AM | InvestorsObserver Analysts

Mentioned in this article

Is SCYNEXIS Inc (SCYX) a Smart Choice in Drug Manufacturers - Specialty & Generic Monday?

The 49 rating InvestorsObserver gives to SCYNEXIS Inc (SCYX) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 67 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, SCYX’s 49 overall rating means the stock scores better than 49 percent of all stocks.

Overall Score - 49
SCYX has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on SCYX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With SCYNEXIS Inc Stock Today?

SCYNEXIS Inc (SCYX) stock is trading at $1.75 as of 9:42 AM on Monday, Oct 23, a decline of -$0.11, or -5.91% from the previous closing price of $1.86. The stock has traded between $1.74 and $1.80 so far today. Volume today is light. So far 3,845 shares have traded compared to average volume of 470,964 shares. Click Here to get the full Stock Report for SCYNEXIS Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App